湖南中医药大学学报2017，Vol.37Issue(3)：336-339,4.DOI:10.3969/j.issn.1674-070X.2017.03.028
平眩方治疗椎动脉型颈椎病(痰瘀阻络证)的临床观察
Clinical Study of Pingxuan Prescription on Vertebral Artery Type of Cervical Spondylosis Patients with Phlegm and Blood Stasis Syndrome
李腾龙 1熊辉 1陆小龙 1齐新宇 2向黎黎 1倪力力1
作者信息
- 1. 湖南中医药大学第二附属医院,湖南 长沙 410005
- 2. 湖南中医药大学,湖南 长沙 410208
- 折叠
摘要
Abstract
Objective To observe the clinical efficacy and safety of Pingxuan Prescription in treating vertebral artery type of cervical spondylosis (phlegm and blood stasis). Methods 60 patients with vertebral artery type of cervical spondylosis were randomly divided into the observation group and control group, 30 cases in each group. Patients in the observation group were treated with Pingxuan prescription and patients in control group were treated with Jingfukang granule. Two groups were treated for four weeks and followed up for half a year. Total clinical effective rate, clinical symptom score, changes of tran-scranial Doppler ultrasound blood flow parameters and related side effects were observed before and after treatment classifica-tion in both groups, separately. Results The total effective rate was 90% in case group and 86.6% in control group. There is no statistical significant between the two groups (P>0.05). The clinical symptom scores of both the two groups were decreased (P<0.05). There was no statistical significant between the two groups after treatment (P>0.05). VA, BA Vs, Vd of the two groups increased in TCD after treating (P<0.05). While the differences between the two groups were not significant (P>0.05). Conclusion Ping Xuan decoction in treating vertebral artery type of cervical spondylosis (phlegm and blood stasis) shows curative effect, low recurrence rate. The total effective rate and clinical symptoms grading score improvement are simil lar with those in Jingfukang group. TCD indicators improvement and long-term curative effect are better than that of con-trol group. It is an effective method for treatment of vertebral artery type of cervical spondylosism, worthy of clinical promotion.关键词
椎动脉型颈椎病/平眩方/痰瘀阻络证Key words
vertebral artery type of cervical spondylosis/Pingxuan prescription/syndrome of phlegm and blood stasis分类
医药卫生引用本文复制引用
李腾龙,熊辉,陆小龙,齐新宇,向黎黎,倪力力..平眩方治疗椎动脉型颈椎病(痰瘀阻络证)的临床观察[J].湖南中医药大学学报,2017,37(3):336-339,4.
